A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
12/2004
12/29/2004	EP1119551B1 Naphthalenecarboxamides as tachykinin receptor antagonists
12/29/2004	EP1003745B1 Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation
12/29/2004	EP0909173B1 Topical administration of certain azaspiranes to prevent or treat skin conditions associated with hyperproliferation of skin cells and/or immunologically mediated disorders
12/29/2004	EP0874626B1 Use of inhibitors of retinoic acid activity for wound healing
12/29/2004	EP0725635B1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
12/29/2004	EP0653940B1 Glial mitogenic factors, their preparation and use
12/29/2004	CN1558950A Somatic cell derived embryonic stem cell and its differentiated cell
12/29/2004	CN1558905A Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
12/29/2004	CN1558895A Compositions for treating acne comprising phytandiol amine
12/29/2004	CN1558772A Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone
12/29/2004	CN1558769A Compositions comprising organic extracts of Geum Japonicum thunb var. and the use thereof
12/29/2004	CN1558765A Enantiomerically pure opioid diarylmethylpiperzine and methods of using same
12/29/2004	CN1558758A Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
12/29/2004	CN1557485A Application of gene recombined human lysozyme in eliminating pathogenic microorganism infection
12/29/2004	CN1557480A Preparation and application of insulin-like growth factors
12/29/2004	CN1557478A Skin, connective tissue and bone growth promoting composition
12/29/2004	CN1557475A Beautifying and fat reducing nutrients composition
12/29/2004	CN1557454A Medicinal composition for treating psoriasis and preparation method thereof
12/29/2004	CN1557442A Liniment for skin and its preparation
12/29/2004	CN1557401A Externally applied medicine for treating clavus, callosity, verruca and ecphyma
12/29/2004	CN1557400A Externally applied Chinese medicinal composition for treating onychomycosis and its preparing process
12/29/2004	CN1557365A Medicine
12/29/2004	CN1557360A Externally applied inflammation diminishing powder for 3 degree burn and scald
12/29/2004	CN1557356A Black soya bean oil contained compound gelling agent
12/29/2004	CN1557350A Frostbite treating medicated wine
12/29/2004	CN1557335A Externally used combined stabilizer of sodium percarbonate
12/29/2004	CN1557333A Chinese traditional medicine composition and its preparation and quality control method thereof
12/29/2004	CN1557326A Whelk treating medicine composition and its preparation method
12/29/2004	CN1557306A Flavescent sophora root essence dispersion tablet
12/29/2004	CN1557300A Use of cnidium fruit element in medicine of treating skin pruritus and the medicine preparation method
12/29/2004	CN1557286A Compound chlorhexidine acetate spray
12/29/2004	CN1557281A Skin apolexis preventing delaying polypeptide and compositions
12/29/2004	CN1182247C Sequence-specific DNA recombination in eukaryotic cells
12/29/2004	CN1182129C Benzopyran derivatives having leukotriene-antagonistic action
12/29/2004	CN1181871C Wolfs milk ointment and its preparation method
12/29/2004	CN1181845C Ointment for treating burn and making process thereof
12/29/2004	CN1181844C Medicine for treating burns and scalds and its preparation process
12/29/2004	CN1181837C Medicine for curing burn and scald
12/29/2004	CN1181834C Medicine for treating pyoderma and its preparing process
12/29/2004	CN1181826C Lipid-based immune regulator composition
12/29/2004	CN1181825C Use of colchinol derivatives in preparation of vascular damaging agents drug
12/29/2004	CN1181738C Therapeutic anti-fungal nail preparation
12/29/2004	CA2529406A1 New use i
12/29/2004	CA2529154A1 Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions
12/29/2004	CA2528313A1 Nail restructuring compositions for topical application
12/29/2004	CA2526642A1 Compositions in the form of a spray comprising a pharmaceutical agent at least one volatile silicone and a non-volatile oily phase
12/29/2004	CA2524739A1 Metronidazole-based green tinted topical pharmaceutical composition
12/28/2004	US6835837 Antiallergens; antiinflammatory agents; skin disorders; osteoporosis
12/28/2004	US6835752 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient
12/28/2004	US6835751 Bicyclic amino acids as pharmaceutical agents
12/28/2004	US6835749 Sulfohydroxamic acids and sulfohydroxamates and their use as MEK inhibitors
12/28/2004	US6835738 Phenylalanine enamide derivatives
12/28/2004	US6835731 Chemokine receptor binding heterocyclic compounds
12/28/2004	US6835724 Corticoid 17,21-dicarboxylic esters and corticosteroid 17-carboxylic ester 21-carbonic esters, processes for their preparation and pharmaceuticals containing these compounds
12/28/2004	US6835711 Use of poly-Glu,Tyr for neuroprotective therapy
12/28/2004	US6835536 Therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, in the treatment of microorganism-caused infections, which infections may be systemic, such as a
12/28/2004	CA2226039C Pyridylfuran and pyridylthiophene compounds
12/23/2004	WO2004111037A1 Cyclic tertiary amine compound
12/23/2004	WO2004111012A1 Imidazolidine derivative
12/23/2004	WO2004111005A1 Anthranylamide pyridones that inhibit vegfr-2 and vegfr-3
12/23/2004	WO2004110988A1 Protease inhibitors
12/23/2004	WO2004110986A1 Benzamide derivative or salt thereof
12/23/2004	WO2004110489A1 MEDICINAL COMPOSITION FOR PREVENTING OR TREATING Th1 TYPE IMMUNOLOGICAL DISEASE
12/23/2004	WO2004110454A1 COMPOSITION FOR TREATMENT FOR OR PREVENTION OF DISEASE NECESSITATING ADMINISTRATION OF ADENOSINE A2a RECEPTOR AGONIST
12/23/2004	WO2004076620A3 Human antibodies specific for interleukin 15 (il-15)
12/23/2004	WO2004064668A3 Horse shoe and medical composition
12/23/2004	WO2004045563A3 Method of treatment of myocardial infarction
12/23/2004	WO2003082198A3 Methods of treatment with lxr modulators
12/23/2004	US20040260096 Novel substituted 4-phenyl-4-{1h-imidazol-2-yl}-piperidine derivatives and their use as selective non-peptide delta opioid agonists
12/23/2004	US20040259949 Aminolevulinulic acid/5-/ and derivatives for healing wounds with heat and photosensitizers for ulcers
12/23/2004	US20040259930 Linear basic compounds having nk-2 antagonist activity and formulations thereof
12/23/2004	US20040259928 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment
12/23/2004	US20040259924 A metabolite of repinotan hydrochloride that have high affinity for binding to the serotonin receptors of the 5-HT1A type; treating stroke or skull-brain trauma; anxiolytic agents; antidepressants; sexual, sleep and food disorders
12/23/2004	US20040259920 Acne treatment
12/23/2004	US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence
12/23/2004	US20040259897 transplant rejection, rheumatoid arthritis, osteoarthritis, diabetes, asthma, inflammatory bowel disease, and chronic obstructive pulmonary disease; inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes
12/23/2004	US20040259894 inhibitors of cyclin-dependent kinases (CDKs); cancer, leukemia, psoriasis
12/23/2004	US20040259893 Use of tyrosine kinase inhibitions for treating allergic diseases
12/23/2004	US20040259879 Antiarthritic agents; colon cancer, neurodegenerative agents
12/23/2004	US20040259864 Substituted pyrimidinone derivatives as ligands of integrin receptors
12/23/2004	US20040259863 Type 4 phosphodiesterase inhibitors and uses thereof
12/23/2004	US20040259840 Using phosphoglycerides, lipid having sphingosine base, glycerides and sterol; wound healing agents; atherosclerosis
12/23/2004	US20040259821 In nonaqueous solvent; therapy for blood disorders; anticancer agents
12/23/2004	US20040259820 Kit for delivering decitabine in vivo
12/23/2004	US20040259815 Synergistic mixture containing tyrosine kinase inhibitor with carotenoils, flavonoids, apigenin
12/23/2004	US20040259781 Drug screening ; polypeptide interfers with binding of fibronectin to; anticancer agents; antihistamines, antiarthritic agents, autoimmune disease, wound healing agents
12/23/2004	US20040259779 Novel neurotrophic factors
12/23/2004	US20040259202 Novel angiogenesis inhibitor
12/23/2004	US20040259201 Recombinant surfactant protein D compositions and methods of use thereof
12/23/2004	US20040259196 T cell receptor variants expressed in mesenchymal cells and uses thereof
12/23/2004	US20040259192 into two fragments, using the human matrix metalloproteinase MMP-3; administering 3-(3-mercaptopropyl)-1-methyl-(1H,3H)quinazoline-2,4-dione and/or 3-(2'-mercaptoethylamino)-2H-1,2,4-benzothiadiazine-1,1-dioxide to treat tumors or diabetic retinopathy; also wound healing, cardiac infarction treatment
12/23/2004	US20040259110 Gene PRV-1 and its use
12/23/2004	US20040258777 Aqueous topical solutions stimulate endothelial growth factors and microcirculation; solvent extraction with volatile non-aqueous solvents; obestity; reduction of cellulite and localized dermal adipose deposits
12/23/2004	US20040258772 Methods of treating angiogenesis, tumor growth, and metastasis
12/23/2004	US20040258722 Water in oil- or oil in water emulsion with glycerol or sorbitol polyol; suncreen agents, creams, lotions; reduced adhesion of sand particles
12/23/2004	US20040258720 Cosmetics; skin disorders, antiinflammatory agents
12/23/2004	US20040258717 Cosmetic and dermatological preparations containing creatine for treating and actively preventing dry skin and other negative alterations of the physiological homeostasis of the healthy-skin
12/23/2004	US20040258689 Augmenting activin induced signaling in cells; screening for complex inhibitors; treatment of reproductive, developmental, skin, bone, hepatic, hematopoietic and/or central nervous system disorders; prostrate cancer
12/23/2004	US20040258678 Isolated nucleic acid having high identity to sequence 215; vectors, host cells, antibodies
12/23/2004	US20040258676 Stimulation of the activity of an isoform of lysyl oxidase for combating against some pathologies due to an incomplete, absent or disorganized elastogenesis

1 ... 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 ... 1065